ALK-Abelló A/S/DKr ALK B
07:00
09:00
11:00
12:55
14:55
1D1W1MYTD1Y5YMAX
About ALK-Abelló A/S
ALK-Abelló A/S is a pharmaceutical company engaged in the development and production of allergy immunotherapy products. Based in Hørsholm, Denmark, the company specializes in allergy treatments that include tablets, injections, and drops targeting common allergens such as grass, tree, and ragweed pollen, as well as house dust mites. Established in the early 20th century, ALK-Abelló has expanded its operations to serve markets globally, with a particular focus on Europe and North America. Its strategic advantage lies in its strong research capabilities and a comprehensive portfolio of allergy treatment options. The company's ongoing investment in innovation supports its goal to transform the treatment of allergies worldwide.
Ticker
DKr ALK B
Sector
Primary listing
CSE
Employees
2,613
Headquarters
Horsholm, Denmark
Website
ALK-Abelló A/S Metrics
BasicAdvanced
kr 53bn
44.00
kr 5.40
0.63
kr 1.60
0.67%
Price and volume
Market cap
kr 53bn
Beta
0.63
52-week high
kr 238.40
52-week low
kr 160.40
Average daily volume
222k
Dividend rate
kr 1.60
Financial strength
Current ratio
3.381
Quick ratio
1.941
Long term debt to equity
5.508
Total debt to equity
6.486
Interest coverage (TTM)
53.68%
Profitability
EBITDA (TTM)
1,900
Gross margin (TTM)
67.24%
Net profit margin (TTM)
18.96%
Operating margin (TTM)
26.36%
Effective tax rate (TTM)
26.79%
Revenue per employee (TTM)
kr 2,420,000
Management effectiveness
Return on assets (TTM)
12.02%
Return on equity (TTM)
20.26%
Valuation
Price to earnings (TTM)
44
Price to revenue (TTM)
8.339
Price to book
8.2
Price to tangible book (TTM)
11.29
Price to free cash flow (TTM)
36.125
Free cash flow yield (TTM)
2.77%
Free cash flow per share (TTM)
6.577
Dividend yield (TTM)
0.67%
Forward dividend yield
0.67%
Growth
Revenue change (TTM)
14.00%
Earnings per share change (TTM)
46.74%
3-year revenue growth (CAGR)
11.85%
10-year revenue growth (CAGR)
9.41%
3-year earnings per share growth (CAGR)
52.92%
10-year earnings per share growth (CAGR)
11.94%
10-year dividend per share growth (CAGR)
20.40%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ALK-Abelló A/S stock?
ALK-Abelló A/S (ALK B) has a market cap of DKr53B as of May 02, 2026.
What is the P/E ratio for ALK-Abelló A/S stock?
The price to earnings (P/E) ratio for ALK-Abelló A/S (ALK B) stock is 44 as of May 02, 2026.
Does ALK-Abelló A/S stock pay dividends?
Yes, the ALK-Abelló A/S (ALK B) stock pays dividends to shareholders. As of May 02, 2026, the dividend rate is DKr1.6 and the yield is 0.67%. ALK-Abelló A/S has a payout ratio of 0% on a trailing twelve-month basis.
When is the next ALK-Abelló A/S dividend payment date?
The next ALK-Abelló A/S (ALK B) dividend payment date is unconfirmed.
What is the beta indicator for ALK-Abelló A/S?
ALK-Abelló A/S (ALK B) has a beta rating of 0.63. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.